Instrument Inactif

Communiqués Cardiovascular Systems, Inc.

Actions

CSII

US1416191062

Equipement, fournitures et distribution médicale

Communiqués

27/04/23	CARDIOVASCULAR SYSTEMS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
13/04/23	Cardiovascular : The Nasdaq Stock Market LLC - Form 8-K	PU
13/04/23	CARDIOVASCULAR SYSTEMS INC : Other Events (form 8-K)	AQ
03/04/23	Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial	BU
29/03/23	CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII	BU
13/02/23	CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII	BU
09/02/23	CARDIOVASCULAR SYSTEMS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
09/02/23	CSII Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Sale of Cardiovascular Systems, Inc. to Abbott Laboratories	AQ
09/02/23	Cardiovascular : Abbott to Acquire Cardiovascular Systems, Inc - Form 8-K	PU
09/02/23	CARDIOVASCULAR SYSTEMS INC : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
09/02/23	Cardiovascular Systems: Fiscal Q2 Earnings Snapshot	AQ
09/02/23	Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results	BU
19/01/23	Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023	BU
12/01/23	Cardiovascular Systems Inc. Enrolls First Patient in Japan for Kaizen Clinical Study	AQ
11/01/23	Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study	BU
04/01/23	Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System	BU
03/01/23	CARDIOVASCULAR SYSTEMS INC : Entry into a Material Definitive Agreement (form 8-K)	AQ
15/12/22	Cardiovascular : Stifel MedTech Madness 2022 Annual West Coast Bus Tour	PU
10/11/22	CARDIOVASCULAR SYSTEMS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
09/11/22	Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences	BU
03/11/22	CARDIOVASCULAR SYSTEMS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
03/11/22	Cardiovascular Systems: Fiscal Q1 Earnings Snapshot	AQ
03/11/22	Cardiovascular : Fiscal Year 2023 First Quarter Earnings Conference Call	PU
03/11/22	Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results	BU
17/10/22	Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems	BU